Home > Qtrly Results > MARKSANS PHARMA

MARKSANS PHARMA
Quarterly Results Analysis [Jun2026]

MARKSANS PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for MARKSANS PHARMA
Please provide your vote to see the results

MARKSANS PHARMA Quarterly Results

Consolidated Jun2026
UnAudited
Mar2026
UnAudited
Dec2025
UnAudited
Sep2025
UnAudited
Jun2025
UnAudited
Mar2025
UnAudited
Dec2024
UnAudited
Sep2024
UnAudited
Revenues ₹841 Cr ₹856 Cr ₹754 Cr ₹720 Cr ₹620 Cr ₹708 Cr ₹682 Cr ₹642 Cr
Expenses ₹628 Cr ₹661 Cr ₹594 Cr ₹576 Cr ₹520 Cr ₹582 Cr ₹551 Cr ₹495 Cr
Operating Income ₹213 Cr ₹195 Cr ₹161 Cr ₹144 Cr ₹100 Cr ₹127 Cr ₹131 Cr ₹147 Cr
Other Income ₹25 Cr ₹35 Cr ₹20 Cr ₹22 Cr ₹6 Cr ₹15 Cr ₹36 Cr ₹0 Cr
Interest ₹7 Cr ₹6 Cr ₹6 Cr ₹6 Cr ₹6 Cr ₹3 Cr ₹3 Cr ₹3 Cr
Depreciation ₹25 Cr ₹24 Cr ₹24 Cr ₹27 Cr ₹23 Cr ₹23 Cr ₹21 Cr ₹20 Cr
Profit Before Tax ₹207 Cr ₹200 Cr ₹151 Cr ₹133 Cr ₹77 Cr ₹116 Cr ₹143 Cr ₹125 Cr
Profit After Tax ₹159 Cr ₹149 Cr ₹114 Cr ₹99 Cr ₹58 Cr ₹91 Cr ₹105 Cr ₹98 Cr
EPS ₹3.47 ₹3.27 ₹2.50 ₹2.17 ₹1.29 ₹2.00 ₹2.31 ₹2.13
Industry Peers & Returns1W1M1Y
MARKSANS PHARMA 3.1% 3.5% 20.1%
SUN PHARMACEUTICAL INDUSTRIES -0.5% 0.8% 19%
DIVIS LABORATORIES 2.2% 23.1% 27.4%
TORRENT PHARMACEUTICALS -2.6% -1.6% 36%
CIPLA 0.8% 2.5% -3.7%
DR REDDYS LABORATORIES 2.6% -2.4% -5.6%
MANKIND PHARMA -1.1% -3.4% -7.2%
LUPIN -4.5% -8.8% 20.8%
ZYDUS LIFESCIENCES 6.2% 4.3% 16.8%

MARKSANS PHARMA Quarterly Revenues

Revenues
Q-o-Q

-1.79 %

Y-o-Y

35.61 %

Quarters Revenues % Change
Jun2026 ₹841 Cr
-1.79
Mar2026 ₹856 Cr
13.48
Dec2025 ₹754 Cr
4.72
Sep2025 ₹720 Cr
16.20
Jun2025 ₹620 Cr
-12.49
Mar2025 ₹708 Cr
3.90
Dec2024 ₹682 Cr
6.22
Sep2024 ₹642 Cr -

MARKSANS PHARMA Quarterly Operating Profit

Operating Profit
Q-o-Q

9.01 %

Y-o-Y

112.77 %

Quarters Operating Profit % Change
Jun2026 ₹213 Cr
9.01
Mar2026 ₹195 Cr
21.57
Dec2025 ₹161 Cr
11.25
Sep2025 ₹144 Cr
44.32
Jun2025 ₹100 Cr
-21.12
Mar2025 ₹127 Cr
-2.73
Dec2024 ₹131 Cr
-11.11
Sep2024 ₹147 Cr -
Operating Margins
Q-o-Q

10.99 %

Y-o-Y

56.90 %

Quarters Operating Margin% % Change
Jun2026 25.34%
10.99
Mar2026 22.83%
7.13
Dec2025 21.31%
6.23
Sep2025 20.06%
24.21
Jun2025 16.15%
-9.88
Mar2025 17.92%
-6.37
Dec2024 19.14%
-16.31
Sep2024 22.87% -

MARKSANS PHARMA Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

6.96 %

Y-o-Y

173.89 %

Quarters Profit After Tax % Change
Jun2026 ₹159 Cr
6.96
Mar2026 ₹149 Cr
31.09
Dec2025 ₹114 Cr
14.68
Sep2025 ₹99 Cr
70.34
Jun2025 ₹58 Cr
-35.85
Mar2025 ₹91 Cr
-13.65
Dec2024 ₹105 Cr
7.47
Sep2024 ₹98 Cr -
PAT Margins
Q-o-Q

8.90 %

Y-o-Y

101.92 %

Quarters PAT Margin(%) % Change
Jun2026 18.96 %
8.90
Mar2026 17.41 %
15.53
Dec2025 15.07 %
9.52
Sep2025 13.76 %
46.54
Jun2025 9.39 %
-26.70
Mar2025 12.81 %
-16.87
Dec2024 15.41 %
1.18
Sep2024 15.23 % -

MARKSANS PHARMA Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

6.12 %

Y-o-Y

168.99 %

Quarters EPS % Change
Jun2026 ₹3.47
6.12
Mar2026 ₹3.27
30.80
Dec2025 ₹2.5
15.21
Sep2025 ₹2.17
68.22
Jun2025 ₹1.29
-35.50
Mar2025 ₹2
-13.42
Dec2024 ₹2.31
8.45
Sep2024 ₹2.13 -

You may also like the below Video Courses